Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.
Fidelity Advisor Health Care Fund - Class I FHCIX
- NAV / 1-Day Return 75.16 / +0.43 %
- Total Assets 3.4B
-
Adj. Expense Ratio
0.710%
- Expense Ratio 0.700%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 74%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis FHCIX
Will FHCIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 7.10 | 237M | Healthcare |
Thermo Fisher Scientific Inc | 6.65 | 222M | Healthcare |
Danaher Corp | 6.61 | 221M | Healthcare |
UnitedHealth Group Inc | 3.20 | 107M | Healthcare |
Johnson & Johnson | 3.06 | 102M | Healthcare |
AbbVie Inc | 2.82 | 94M | Healthcare |
Natera Inc | 2.75 | 92M | Healthcare |
Merck & Co Inc | 2.56 | 86M | Healthcare |
West Pharmaceutical Services Inc | 2.54 | 85M | Healthcare |
argenx SE ADR | 2.28 | 76M | Healthcare |